Monitoring Solution Structures of Peroxisome Proliferator-Activated Receptor β/δ upon Ligand Binding.
Peroxisome proliferator-activated receptors (PPARs) have been intensively studied as drug targets to treat type 2 diabetes, lipid disorders, and metabolic syndrome. This study is part of our ongoing efforts to map conformational changes in PPARs in solution by a combination of chemical cross-linking...
Main Authors: | Rico Schwarz, Dirk Tänzler, Christian H Ihling, Andrea Sinz |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2016-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4798536?pdf=render |
Similar Items
-
Binding and activity of bisphenol analogues to human peroxisome proliferator-activated receptor β/δ
by: Chuan-Hai Li, et al.
Published: (2021-12-01) -
Ligand-Activated Peroxisome Proliferator-Activated Receptor β/δ Facilitates Cell Proliferation in Human Cholesteatoma Keratinocytes
by: Chen Zhang, et al.
Published: (2020-01-01) -
Peroxisome Proliferator-Activated Receptor β/δ in the Brain: Facts and Hypothesis
by: M. G. Hall, et al.
Published: (2008-01-01) -
To study the effect of peroxisome proliferator activated receptor β/δ (PPAR-β/δ) in the nephrogenic anemia
by: YU, HUNG-LIN, et al.
Published: (2018) -
Contributions of peroxisome proliferator-activated receptor β/δ to skin health and disease
by: Montagner Alexandra, et al.
Published: (2013-02-01)